[Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D008937:Mitomycins / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D013852:Thiotepa; D005474:Fluoxymesterone; D005472:Fluorouracil
Les associations sont-elles plus actives que des monothérapies en matière de chimiothérapie anticancéreuse?